Estradiol valerate/dienogest: a novel combined oral contraceptive.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Therapeutics

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clinthera.2011.11.006PMID 22169052
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Low-Dose Ethinylestradiol/Levonorgestrel

  2012cited by this paper
• Effective Treatment of Heavy Menstrual Bleeding With Estradiol Valerate and Dienogest: A Randomized Controlled Trial

  2011cited by this paper
• Contraceptive efficacy of a combined oral contraceptive containing ethinyloestradiol 20 μg/drospirenone 3mg administered in a 24/4 regimen: a pooled analysis of four open-label studies.

  2011cited by this paper
• Hemostatic Effects of a Novel Estradiol-Based Oral Contraceptive

  2011cited by this paper
• After 50 years of ethinylestradiol, another oestrogen in combined oral contraceptives

  2010cited by this paper
• New regimens with combined oral contraceptive pills – moving away from traditional 21/7 cycles

  2010cited by this paper
• History of oral contraception

  2010cited by this paper
• Evaluation of a new estradiol oral contraceptive: estradiol valerate and dienogest

  2010cited by this paper
• The use of newer progestins for contraception.

  2010cited by this paper
• Ethinylestradiol/Dienogest in Oral Contraception

  2010cited by this paper
• Efficacy and safety of a novel oral contraceptive based on oestradiol (oestradiol valerate/dienogest): a Phase III trial.

  2010cited by this paper
• Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest

  2009cited by this paper
• Estradiol Valerate/Dienogest

  2009cited by this paper
• O319 A novel oral contraceptive comprising estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding without organic cause: a double‐blind, randomised, placebo‐controlled trial

  2009cited by this paper
• The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study

  2009cited by this paper
• Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl estradiol/levonorgestrel.

  2009cited by this paper
• Ovulation inhibition with four variations of a four-phasic estradiol valerate/dienogest combined oral contraceptive: results of two prospective, randomized, open-label studies.

  2008cited by this paper
• Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.

  2006cited by this paper
• Chemical birth of the pill. 1992.

  2006cited by this paper
• Chemical birth of the pill

  2006cited by this paper
• Rationale for decreasing the number of days of the hormone-free interval with use of low-dose oral contraceptive formulations.

  2005cited by this paper
• Effect of four oral contraceptives on hemostatic parameters.

  2004cited by this paper
• Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone

  2004cited by this paper
• Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone.

  2004cited by this paper
• Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.

  2003cited by this paper
• Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters.

  2003cited by this paper
• Effect of dienogest-containing oral contraceptives on lipid metabolism.

  2002cited by this paper
• Drug Interactions Between Oral Contraceptives and Antibiotics

  2001cited by this paper
• The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 microg and ethinylestradiol 15 microg.

  1999cited by this paper
• The pharmacological profile of dienogest

  1999cited by this paper
• Candesartan cilexetil: development and preclinical studies.

  1999cited by this paper
• ALTERNATIVES FOR THE REPLACEMENT OF ETHINYLESTRADIOL BY NATURAL 17BETA -ESTRADIOL IN DIENOGEST-CONTAINING ORAL CONTRACEPTIVES

  1999cited by this paper
• Causes and consequences of oral contraceptive noncompliance.

  1999cited by this paper
• Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives.

  1998cited by this paper
• Inhibition of ovulation by an oral contraceptive containing 100 μg levonorgestrel in combination with 20 μg ethinylestradiol

  1996cited by this paper
• Inhibition of ovulation by an oral contraceptive containing 100 micrograms levonorgestrel in combination with 20 micrograms ethinylestradiol.

  1996cited by this paper
• Oral contraceptive containing natural estradiol for premenopausal women.

  1995cited by this paper
• Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol.

  1993cited by this paper
• Ultrasound evaluation of ovarian activity under oral contraceptives.

  1993cited by this paper
• Pill failure and non-use of secondary precautions.

  1992cited by this paper
• The Effect of Doxycycline on Serum Levels of Ethinyl Estradiol, Norethindrone, and Endogenous Progesterone

  1991cited by this paper
• The effect of tetracycline on levels of oral contraceptives.

  1991cited by this paper
• Clinical gynecologic endocrinology and infertility

  1991cited by this paper
• Inadvertent pregnancies in oral contraceptive users

  1989cited by this paper
• Inadvertent pregnancies in oral contraceptive users.

  1989cited by this paper
• Pill method failures.

  1987cited by this paper
• Ovulation inhibition with 17 beta-estradiol cyclo-octyl acetate and desogestrel.

  1987cited by this paper
• Pill method failures.

  1987cited by this paper
• Ovulation Inhibition with 17β‐Estradiol Cyclo‐Octyl Acetate and Desogestrel

  1987cited by this paper
• Pharmacokinetic and pharmacological features of oestradiol valerate.

  1982cited by this paper
• A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.

  1980cited by this paper
• The Effect of Ampicillin on Oral Contraceptive Effectiveness

  1980cited by this paper
• A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens

  1980cited by this paper
• CLINICAL TRIAL OF A NEW ORAL CONTRACEPTIVE PILL CONTAINING THE NATURAL OESTROGEN 17β‐OESTRADIOL

  1979cited by this paper
• Natural oestrogens for oral contraception.

  1979cited by this paper
• Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol.

  1979cited by this paper
• Combined oral contraceptives.

  1978cited by this paper
• International Journal of Women's Health Dovepress Endometrial Safety of an Oral Contraceptive Containing Estradiol Valerate and Dienogest

  year unknowncited by this paper

• Review of hormonal replacement therapy options for the treatments of menopausal symptoms

  2025influential citation
• Hormonal Contraception in Perimenopause: What to Consider to Guide the Choice

  2025cites this paper
• Tales from the clinic: Contraception and perimenopause

  2024cites this paper
• Hormonal and natural contraceptives: a review on efficacy and risks of different methods for an informed choice

  2023cites this paper
• Non-contraceptive Benefits of Hormonal Methods

  2021cites this paper
• Combined Oral Contraceptives and Venous Thromboembolism: Review and Perspective to Mitigate the Risk

  2021cites this paper
• Oestrogen component of COCs: have we finally found a replacement for ethinyl estradiol?

  2021cites this paper
• Application of Validated TLC-Densitometric Method for Determination of Estradiol Valeratе in Tablets

  2020cites this paper
• Pooled analysis of bleeding profile, efficacy and safety of oral oestradiol valerate/dienogest in women aged 25 and under

  2020cites this paper
• Protocolo clínico para prescrição farmacêutica de contraceptivos hormonais em âmbito institucional

  2020cites this paper
• Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.

  2020cites this paper
• The Interaction Test of Binary Mixtures of Endocrine-Disrupting Chemicals Using In Vitro Bioassays

  2020cites this paper
• Contraception modes: increasing women’s commitment to modern combined oral contraceptives with the shortest possible hormone-free interval

  2020cites this paper
• Assessment of 16srRNA Methylase Genes Among Non-ESBL and ESBL-Producing Klebsiella pneumoniae Isolates

  2020cites this paper
• Do Norwegian providers comply with national recommendations when prescribing combined oral contraceptives to starters? A cohort study

  2019cites this paper
• Venous Thrombotic Risk in Transgender Women Undergoing Estrogen Therapy: A Systematic Review and Metaanalysis.

  2019cites this paper
• Use of oral contraceptives for management of acne vulgaris and hirsutism in women of reproductive and late reproductive age

  2018cites this paper
• Estradiol valerate and dienogest in hormonal contraception. Acceptability and effectiveness in real clinical practice

  2018cites this paper
• Estrogen-mediated Height Control in Girls with Marfan Syndrome

  2016cites this paper
• Choosing a combined oral contraceptive pill.

  2015cites this paper
• Trends und künftige Entwicklungen

  2014cites this paper
• An Improved Synthesis of Nomegestrol Acetate

  2014cites this paper
• Temperature-driven isosymmetric reversible phase transition of the hormone estradiol 17β valerate

  2014cites this paper
• Novel oral contraceptive for heavy menstrual bleeding: estradiol valerate and dienogest

  2013cites this paper
• β-estradiol 17-valerate affects embryonic development and sexual differentiation in Japanese medaka (Oryzias latipes).

  2013cites this paper
• Interações medicamentosas envolvendo contracetivos hormonais

  2013cites this paper
• Contraception: A Casebook From Menarche To Menopause

  2013cites this paper
• A New Contraceptive Pill Containing 17β-Estradiol and Nomegestrol Acetate

  2013cites this paper
• Medical treatment of idiopathic heavy menstrual bleeding. What is new? An evidence based approach

  2013cites this paper
• History of oral contraceptive drugs and their use worldwide.

  2013cites this paper
• New developments in oral contraception: clinical utility of estradiol valerate/dienogest (Natazia ® ) for contraception and for treatment of heavy menstrual bleeding: patient considerations

  2012cites this paper